Outcomes of Severe COPD Exacerbations Requiring Hospitalization

 

 Buy Article Permissions and Reprints

ABSTRACT

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are important events in the lives of patients with COPD. While several definitions exist for AECOPD, exacerbations that result in a hospitalization would nearly always be considered severe. On average, exacerbation rates are ∼1 to 2 per patient-year with COPD hospitalizations averaging ∼0.1 to 0.2 per patient-year. Many risk factors, some of which are modifiable, such as patient adherence to therapy, pulmonary rehabilitation, and type of medication used, influence the rate of AECOPD. Severe AECOPD that result in hospitalization often lead to several adverse affects, including decreased quality of life, diminished lung function, weakness, reexacerbations/rehospitalization, cardiopulmonary complications, and death. Preventing severe AECOPD and their sequelae is a critical component in treating our patients with COPD.

REFERENCES

• 1 Rabe K F, Hurd S, Anzueto A Global Initiative for Chronic Obstructive Lung Disease et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.  Am J Respir Crit Care Med. 2007;  176 532-555
  CrossrefPubMedGoogle Scholar
• 2 Mannino D M, Buist A S. Global burden of COPD: risk factors, prevalence, and future trends.  Lancet. 2007;  370 765-773
  CrossrefPubMedGoogle Scholar
• 3 Mannino D M, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease.  Proc Am Thorac Soc. 2007;  4 502-506
  CrossrefPubMedGoogle Scholar
• 4 Holguin F, Folch E, Redd S C, Mannino D M. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.  Chest. 2005;  128 2005-2011
  CrossrefPubMedGoogle Scholar
• 5 Johnston A K, Mannino D M. Epidemiology of COPD exacerbations. In: Wedzicha JA, Martinez FJ Exacerbations of Chronic Obstructive Pulmonary Disease. London, UK; Informa Healthcare 2008: 15-26
  PubMedGoogle Scholar
• 6 Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations.  Chest. 2000;  117(5, Suppl 2) 398S-401S
  CrossrefPubMedGoogle Scholar
• 7 Effing T W, Kerstjens H A, Monninkhof E M et al.. Definitions of exacerbations: does it really matter in clinical trials on COPD?.  Chest. 2009;  136 918-923
  CrossrefPubMedGoogle Scholar
• 8 Celli B R, MacNee W. ATS/ERS Task Force . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.  Eur Respir J. 2004;  23 932-946
  CrossrefPubMedGoogle Scholar
• 9 Bahadori K, FitzGerald J M, Levy R D, Fera T, Swiston J. Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.  Can Respir J. 2009;  16 e43-e49
  CrossrefPubMedGoogle Scholar
• 10 Briggs A, Spencer M, Wang H, Mannino D, Sin D D. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease.  Arch Intern Med. 2008;  168 71-79
  CrossrefPubMedGoogle Scholar
• 11 de Melo M N, Ernst P, Suissa S. Rates and patterns of chronic obstructive pulmonary disease exacerbations.  Can Respir J. 2004;  11 559-564
  PubMedGoogle Scholar
• 12 Balcells E, Antó J M, Gea J PAC-COPD Study Group et al. Characteristics of patients admitted for the first time for COPD exacerbation.  Respir Med. 2009;  103 1293-1302
  CrossrefPubMedGoogle Scholar
• 13 Garcia-Aymerich J, Barreiro E, Farrero E, Marrades R M, Morera J, Antó J M. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study).  Eur Respir J. 2000;  16 1037-1042
  CrossrefPubMedGoogle Scholar
• 14 Garcia-Aymerich J, Monsó E, Marrades R M EFRAM Investigators et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study.  Am J Respir Crit Care Med. 2001;  164 1002-1007
  CrossrefPubMedGoogle Scholar
• 15 Vestbo J, Rasmussen F V. Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease.  Eur Respir J. 1989;  2 710-715
  PubMedGoogle Scholar
• 16 Dial S, Menzies D. Is there a role for mask continuous positive airway pressure in acute respiratory failure due to COPD? Lessons from a retrospective audit of 3 different cohorts.  Int J Chron Obstruct Pulmon Dis. 2006;  1 65-72
  PubMedGoogle Scholar
• 17 Chandra D, Tsai C L, Camargo Jr C A. Acute exacerbations of COPD: delay in presentation and the risk of hospitalization.  COPD. 2009;  6 95-103
  CrossrefPubMedGoogle Scholar
• 18 Lee T A, Schumock G T, Bartle B, Pickard A S. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.  Pharmacotherapy. 2009;  29 1039-1053
  CrossrefPubMedGoogle Scholar
• 19 Patel I S, Seemungal T A, Wilks M, Lloyd-Owen S J, Donaldson G C, Wedzicha J A. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.  Thorax. 2002;  57 759-764
  CrossrefPubMedGoogle Scholar
• 20 Groenewegen K H, Postma D S, Hop W C, Wielders P L, Schlösser N J, Wouters E F. COSMIC Study Group . Increased systemic inflammation is a risk factor for COPD exacerbations.  Chest. 2008;  133 350-357
  CrossrefPubMedGoogle Scholar
• 21 Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  159 158-164
  CrossrefPubMedGoogle Scholar
• 22 Oostenbrink J B, Rutten-van Mölken M P. Resource use and risk factors in high-cost exacerbations of COPD.  Respir Med. 2004;  98 883-891
  CrossrefPubMedGoogle Scholar
• 23 Garcia-Aymerich J, Farrero E, Félez M A, Izquierdo J, Marrades R M, Antó J M. Estudi del Factors de Risc d'Agudització de la MPOC investigators . Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.  Thorax. 2003;  58 100-105
  CrossrefPubMedGoogle Scholar
• 24 Wong A W, Gan W Q, Burns J, Sin D D, van Eeden S F. Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates.  Can Respir J. 2008;  15 361-364
  CrossrefPubMedGoogle Scholar
• 25 Baker E H, Wood D M, Brennan A L, Clark N, Baines D L, Philips B J. Hyperglycaemia and pulmonary infection.  Proc Nutr Soc. 2006;  65 227-235
  CrossrefPubMedGoogle Scholar
• 26 Anderson H R, Spix C, Medina S et al.. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project.  Eur Respir J. 1997;  10 1064-1071
  CrossrefPubMedGoogle Scholar
• 27 Wongsurakiat P, Maranetra K N, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.  Chest. 2004;  125 2011-2020
  CrossrefPubMedGoogle Scholar
• 28 Jennings J H, Digiovine B, Obeid D, Frank C. The association between depressive symptoms and acute exacerbations of COPD.  Lung. 2009;  187 128-135
  CrossrefPubMedGoogle Scholar
• 29 McGhan R, Radcliff T, Fish R, Sutherland E R, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD.  Chest. 2007;  132 1748-1755
  CrossrefPubMedGoogle Scholar
• 30 Abusaid G H, Barbagelata A, Tuero E, Mahmood A, Sharma G. Diastolic dysfunction and COPD exacerbation.  Postgrad Med. 2009;  121 76-81
  CrossrefPubMedGoogle Scholar
• 31 Vestbo J, Anderson J A, Calverley P et al.. Adherence to inhaled therapy, mortality, and hospital admission in COPD.  Thorax. 2009;  64 939-943
  CrossrefPubMedGoogle Scholar
• 32 Puhan M, Scharplatz M, Troosters T, Walters E H, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.  Cochrane Database Syst Rev. 2009;  (1) CD005305
  PubMedGoogle Scholar
• 33 Ko F W, Ip M, Chan P K et al.. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD.  Chest. 2007;  131 44-52
  CrossrefPubMedGoogle Scholar
• 34 Seemungal T A, Donaldson G C, Paul E A, Bestall J C, Jeffries D J, Wedzicha J A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1998;  157(5 Pt 1) 1418-1422
  CrossrefPubMedGoogle Scholar
• 35 Postma D S, Sluiter H J. Prognosis of chronic obstructive pulmonary disease: the Dutch experience.  Am Rev Respir Dis. 1989;  140(3 Pt 2) S100-S105
  PubMedGoogle Scholar
• 36 Hodgkin J E. Prognosis in chronic obstructive pulmonary disease.  Clin Chest Med. 1990;  11 555-569
  PubMedGoogle Scholar
• 37 Wang Q, Bourbeau J. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD.  Respirology. 2005;  10 334-340
  CrossrefPubMedGoogle Scholar
• 38 Atiş S, Kanik A, Ozgür E S, Eker S, Tümkaya M, Ozge C. How exactly can we predict the prognosis of COPD [in Turkish].  Tuberk Toraks. 2009;  57 289-297
  PubMedGoogle Scholar
• 39 Tsai C L, Camargo Jr C A. The role of body mass index in acute exacerbations of chronic obstructive pulmonary disease.  Emerg Med J. 2009;  26 701-705
  CrossrefPubMedGoogle Scholar
• 40 Skyba P, Kluchova Z, Joppa P, Petrasova D, Tkacova R. Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD.  Med Sci Monit. 2009;  15 CR528-CR533
  PubMedGoogle Scholar
• 41 Tsimogianni A M, Papiris S A, Stathopoulos G T, Manali E D, Roussos C, Kotanidou A. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease.  J Gen Intern Med. 2009;  24 1043-1048
  CrossrefPubMedGoogle Scholar
• 42 ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation . Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines.  Chest. 1997;  112 1363-1396
  CrossrefPubMedGoogle Scholar
• 43 Puhan M A, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality — a systematic review.  Respir Res. 2005;  6 54
  CrossrefPubMedGoogle Scholar
• 44 Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction.  Eur Respir J. 1999;  13 125-132
  CrossrefPubMedGoogle Scholar
• 45 Johnston A K, Mannino D M, Hagan G W, Davis K J, Kiri V A. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.  Thorax. 2008;  63 599-605
  CrossrefPubMedGoogle Scholar
• 46 Baker E H, Janaway C H, Philips B J et al.. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease.  Thorax. 2006;  61 284-289
  CrossrefPubMedGoogle Scholar
• 47 Arbex M A, de Souza Conceição G M, Cendon S P et al.. Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits.  J Epidemiol Community Health. 2009;  63 777-783
  CrossrefPubMedGoogle Scholar
• 48 Sunyer J, Antó J M, Murillo C, Saez M. Effects of urban air pollution on emergency room admissions for chronic obstructive pulmonary disease.  Am J Epidemiol. 1991;  134 277-286 discussion 287-289
  PubMedGoogle Scholar
• 49 Nichol K L, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease.  Arch Intern Med. 1999;  159 2437-2442
  CrossrefPubMedGoogle Scholar
• 50 Leech J A, Gervais A, Ruben F L. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.  CMAJ. 1987;  136 361-365
  PubMedGoogle Scholar
• 51 Davis A L, Aranda C P, Schiffman G, Christianson L C. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease: a pilot study.  Chest. 1987;  92 204-212
  CrossrefPubMedGoogle Scholar
• 52 Steentoft J, Konradsen H B, Hilskov J, Gislason G, Andersen J R. Response to pneumococcal vaccine in chronic obstructive lung disease—the effect of ongoing, systemic steroid treatment.  Vaccine. 2006;  24 1408-1412
  CrossrefPubMedGoogle Scholar
• 53 Sumitani M, Tochino Y, Kamimori T, Fujiwara H, Fujikawa T. Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients.  Intern Med. 2008;  47 1189-1197
  CrossrefPubMedGoogle Scholar
• 54 Cao Z, Ong K C, Eng P, Tan W C, Ng T P. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors.  Respirology. 2006;  11 188-195
  CrossrefPubMedGoogle Scholar
• 55 Ng T P, Niti M, Tan W C, Cao Z, Ong K C, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.  Arch Intern Med. 2007;  167 60-67
  CrossrefPubMedGoogle Scholar
• 56 Laurin C, Labrecque M, Dupuis G, Bacon S L, Cartier A, Lavoie K L. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations.  Psychosom Med. 2009;  71 667-674
  CrossrefPubMedGoogle Scholar
• 57 Burrows B, Kettel L J, Niden A H, Rabinowitz M, Diener C F. Patterns of cardiovascular dysfunction in chronic obstructive lung disease.  N Engl J Med. 1972;  286 912-918
  CrossrefPubMedGoogle Scholar
• 58 Barberà J A, Peinado V I, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease.  Eur Respir J. 2003;  21 892-905
  CrossrefPubMedGoogle Scholar
• 59 Kessler R, Faller M, Weitzenblum E et al.. “Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease.  Am J Respir Crit Care Med. 2001;  164 219-224
  CrossrefPubMedGoogle Scholar
• 60 Stockley R A. Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention.  Curr Med Res Opin. 2009;  25 1235-1245
  CrossrefPubMedGoogle Scholar
• 61 Donaldson G C, Seemungal T A, Patel I S, Lloyd-Owen S J, Wilkinson T M, Wedzicha J A. Longitudinal changes in the nature, severity and frequency of COPD exacerbations.  Eur Respir J. 2003;  22 931-936
  CrossrefPubMedGoogle Scholar
• 62 Esteban C, Quintana J M, Moraza J et al.. Impact of hospitalisations for exacerbations of COPD on health-related quality of life.  Respir Med. 2009;  103 1201-1208
  CrossrefPubMedGoogle Scholar
• 63 Makris D, Moschandreas J, Damianaki A et al.. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.  Respir Med. 2007;  101 1305-1312
  CrossrefPubMedGoogle Scholar
• 64 Spruit M A, Gosselink R, Troosters T et al.. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.  Thorax. 2003;  58 752-756
  CrossrefPubMedGoogle Scholar
• 65 Lange P. Chronic obstructive pulmonary disease and risk of infection.  Pneumonol Alergol Pol. 2009;  77 284-288
  PubMedGoogle Scholar
• 66 Zvezdin B, Milutinov S, Kojicic M et al.. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation.  Chest. 2009;  136 376-380
  CrossrefPubMedGoogle Scholar
• 67 Brekke P H, Omland T, Smith P, Søyseth V. Underdiagnosis of myocardial infarction in COPD—Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation.  Respir Med. 2008;  102 1243-1247
  CrossrefPubMedGoogle Scholar
• 68 Hanaoka M, Ideura G, Ito M et al.. Pulmonary haemodynamic changes in patients with severe COPD.  Respirology. 2008;  13 919-922
  CrossrefPubMedGoogle Scholar
• 69 Weitzenblum E, Chaouat A. Cor pulmonale.  Chron Respir Dis. 2009;  6 177-185
  CrossrefPubMedGoogle Scholar
• 70 Soler-Cataluña J J, Martínez-García M A, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.  Thorax. 2005;  60 925-931
  CrossrefPubMedGoogle Scholar
• 71 Fruchter O, Yigla M. Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.  Respirology. 2008;  13 851-855
  CrossrefPubMedGoogle Scholar
• 72 Donaldson G C, Seemungal T A, Bhowmik A, Wedzicha J A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.  Thorax. 2002;  57 847-852
  CrossrefPubMedGoogle Scholar
• 73 Eisner M D, Blanc P D, Yelin E H et al.. COPD as a systemic disease: impact on physical functional limitations.  Am J Med. 2008;  121 789-796
  CrossrefPubMedGoogle Scholar
• 74 Aimonino N, Tibaldi V, Barale S et al.. Depressive symptoms and quality of life in elderly patients with exacerbation of chronic obstructive pulmonary disease or cardiac heart failure: preliminary data of a randomized controlled trial.  Arch Gerontol Geriatr. 2007;  44(Suppl 1) 7-12
  CrossrefPubMedGoogle Scholar
• 75 Cote C G, Dordelly L J, Celli B R. Impact of COPD exacerbations on patient-centered outcomes.  Chest. 2007;  131 696-704
  CrossrefPubMedGoogle Scholar
• 76 Kohansal R, Martinez-Camblor P, Agustí A, Buist A S, Mannino D M, Soriano J B. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort.  Am J Respir Crit Care Med. 2009;  180 3-10
  CrossrefPubMedGoogle Scholar
• 77 Curkendall S M, Lanes S, de Luise C et al.. Chronic obstructive pulmonary disease severity and cardiovascular outcomes.  Eur J Epidemiol. 2006;  21 803-813
  CrossrefPubMedGoogle Scholar

David M ManninoM.D. 

Division of Pulmonary and Critical Care Medicine, University of Kentucky Medical Center

740 S. Limestone, L–548, Lexington, KY 40536

Email: dmannino@uky.edu